Core Insights - Meliodays Medical and Celanese Corporation have partnered to develop MelioOne®, a hormone-free intrauterine device (IUD) aimed at providing localized relief for menstrual pain [1][2] - The collaboration marks a significant step towards improving menstrual pain management solutions, targeting pain at its source while minimizing systemic side effects [2] Company Overview Meliodays Medical - Meliodays Medical GmbH is focused on developing hormone-free therapies for menstrual pain, addressing a significant unmet medical need [3] - The company aims to enhance the quality of life for menstruating individuals by providing effective pain relief without affecting the menstrual cycle [3] Celanese Corporation - Celanese is a global leader in chemistry, producing specialty material solutions across various industries, with 2024 net sales reported at $10.3 billion [4] - The company emphasizes sustainability and responsible management of materials, aiming to create value for customers and stakeholders [4]